Pharmaceuticals

Mediterranean Fish Vaccine Market was valued at US$ 96,323.46 Million in 2022 and is expected to reach US$ 209,030.80 Million by 2030; it is estimated to record a CAGR of 10.2% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Mediterranean Fish Vaccine Market was valued at US$ 96,323.46 Million in 2022 and is expected to reach US$ 209,030.80 Million by 2030; it is estimated to record a CAGR of 10.2% from 2022 to 2030

Market News Insights January 30, 2025

Based on region, the Mediterranean fish vaccine market is divided into France, Italy, Spain, Egypt, Greece, Turkey,...

Read More Read more about Mediterranean Fish Vaccine Market was valued at US$ 96,323.46 Million in 2022 and is expected to reach US$ 209,030.80 Million by 2030; it is estimated to record a CAGR of 10.2% from 2022 to 2030

Paracetamol Market was valued at US$ 9,993.29 Million in 2022 and is expected to reach US$ 14,254.44 Million by 2030; it is estimated to record a CAGR of 4.5% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Paracetamol Market was valued at US$ 9,993.29 Million in 2022 and is expected to reach US$ 14,254.44 Million by 2030; it is estimated to record a CAGR of 4.5% from 2022 to 2030

Market News Insights January 24, 2025

In the paracetamol market report, North America accounted for the largest share of the global paracetamol market...

Read More Read more about Paracetamol Market was valued at US$ 9,993.29 Million in 2022 and is expected to reach US$ 14,254.44 Million by 2030; it is estimated to record a CAGR of 4.5% from 2022 to 2030

Small Cell Lung Cancer (SCLC) Treatment Market was valued at US$ 4,480.85 Million in 2022 and is expected to reach to US$ 9,173.60 Million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030

• Pharmaceuticals

Small Cell Lung Cancer (SCLC) Treatment Market was valued at US$ 4,480.85 Million in 2022 and is expected to reach to US$ 9,173.60 Million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030

Market News Insights January 23, 2025

Combination Therapy for Small Cell Lung Cancer Treatment Market Combination therapy for lung cancer treatment is the...

Read More Read more about Small Cell Lung Cancer (SCLC) Treatment Market was valued at US$ 4,480.85 Million in 2022 and is expected to reach to US$ 9,173.60 Million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030

Homeopathy Market was valued at US$ 6,016.14 Million in 2022 and is expected to reach US$ 18,069.91 Million by 2030; it is estimated to record a CAGR of 14.7% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Homeopathy Market was valued at US$ 6,016.14 Million in 2022 and is expected to reach US$ 18,069.91 Million by 2030; it is estimated to record a CAGR of 14.7% from 2022 to 2030

Market News Insights January 22, 2025

Safety Associated with Homeopathic Products for Homeopathy Market Growth During Forecast Period Homeopathic medicines are widely considered...

Read More Read more about Homeopathy Market was valued at US$ 6,016.14 Million in 2022 and is expected to reach US$ 18,069.91 Million by 2030; it is estimated to record a CAGR of 14.7% from 2022 to 2030

America & Europe Eye Drops Market was valued at US$ 13.16 Billion in 2023 and is expected to reach US$ 19.88 Billion by 2031; it is estimated to record a CAGR of 5.3% from 2023 to 2031

• Life Sciences
• Pharmaceuticals

America & Europe Eye Drops Market was valued at US$ 13.16 Billion in 2023 and is expected to reach US$ 19.88 Billion by 2031; it is estimated to record a CAGR of 5.3% from 2023 to 2031

Market News Insights January 14, 2025

High Incidence of Age-Related Eye Diseases Drives America & Europe Eye Drops Market Aging is a prominent...

Read More Read more about America & Europe Eye Drops Market was valued at US$ 13.16 Billion in 2023 and is expected to reach US$ 19.88 Billion by 2031; it is estimated to record a CAGR of 5.3% from 2023 to 2031

Idiopathic Pulmonary Fibrosis Treatment Market was valued at US$ 4,360.87 Million in 2022 and is expected to reach to US$ 10,784.07 Million by 2030; it is estimated to record a CAGR of 12.0% from 2022 to 2030

• Pharmaceuticals

Idiopathic Pulmonary Fibrosis Treatment Market was valued at US$ 4,360.87 Million in 2022 and is expected to reach to US$ 10,784.07 Million by 2030; it is estimated to record a CAGR of 12.0% from 2022 to 2030

Market News Insights January 13, 2025

North America accounted for a major share of the global idiopathic pulmonary fibrosis treatment market in 2022....

Read More Read more about Idiopathic Pulmonary Fibrosis Treatment Market was valued at US$ 4,360.87 Million in 2022 and is expected to reach to US$ 10,784.07 Million by 2030; it is estimated to record a CAGR of 12.0% from 2022 to 2030

Sialorrhea Treatment Market was valued at US$ 695.06 Million in 2022 and is expected to reach to US$ 1,042.37 Million by 2030; it is estimated to record a CAGR of 5.2% from 2022 to 2030

• Pharmaceuticals

Sialorrhea Treatment Market was valued at US$ 695.06 Million in 2022 and is expected to reach to US$ 1,042.37 Million by 2030; it is estimated to record a CAGR of 5.2% from 2022 to 2030

Market News Insights January 9, 2025

Availability of Various Treatment Options for Sialorrhea Drives Sialorrhea Treatment Market Growth Treatments for sialorrhea include behavioral...

Read More Read more about Sialorrhea Treatment Market was valued at US$ 695.06 Million in 2022 and is expected to reach to US$ 1,042.37 Million by 2030; it is estimated to record a CAGR of 5.2% from 2022 to 2030

Vitamin K2 Market was valued at US$ 1,44,571.42 Thousands in 2022 and is expected to reach US$ 11,60,779.02 Thousands by 2030; it is estimated to record a CAGR of 29.7% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Vitamin K2 Market was valued at US$ 1,44,571.42 Thousands in 2022 and is expected to reach US$ 11,60,779.02 Thousands by 2030; it is estimated to record a CAGR of 29.7% from 2022 to 2030

Market News Insights January 8, 2025

Regulatory Considerations and Standards Would Lead to Future Trends in Market As the popularity of vitamin K2...

Read More Read more about Vitamin K2 Market was valued at US$ 1,44,571.42 Thousands in 2022 and is expected to reach US$ 11,60,779.02 Thousands by 2030; it is estimated to record a CAGR of 29.7% from 2022 to 2030

Radioactive Tracer Market was valued at US$ 14,675.73 Million in 2022 and is expected to reach US$ 54,296.57 Million by 2030; it is estimated to record a CAGR of 17.8% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Radioactive Tracer Market was valued at US$ 14,675.73 Million in 2022 and is expected to reach US$ 54,296.57 Million by 2030; it is estimated to record a CAGR of 17.8% from 2022 to 2030

Market News Insights January 7, 2025

New Initiatives for Radioactive Tracer Market Growth During Forecast Period    The European Union Committee has taken...

Read More Read more about Radioactive Tracer Market was valued at US$ 14,675.73 Million in 2022 and is expected to reach US$ 54,296.57 Million by 2030; it is estimated to record a CAGR of 17.8% from 2022 to 2030

Vegetarian Capsules Market was valued at US$ 1.8 Billion in 2023 and is expected to reach US$ 3.5 Billion by 2031; it is estimated to record a CAGR of 8.4% from 2023 to 2031

• Life Sciences
• Pharmaceuticals

Vegetarian Capsules Market was valued at US$ 1.8 Billion in 2023 and is expected to reach US$ 3.5 Billion by 2031; it is estimated to record a CAGR of 8.4% from 2023 to 2031

Market News Insights January 2, 2025

Rising Preference for Vegan Capsules Over Gelatin-Based Capsules For many years, there have been medical, religious, cultural,...

Read More Read more about Vegetarian Capsules Market was valued at US$ 1.8 Billion in 2023 and is expected to reach US$ 3.5 Billion by 2031; it is estimated to record a CAGR of 8.4% from 2023 to 2031